{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:21:18Z","timestamp":1793532078119,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.008","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T11:18:10Z","timestamp":1253099890000},"page":"6887-6893","source":"Crossref","is-referenced-by-count":70,"title":["Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: A randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"27","author":[{"given":"Suman","family":"Kanungo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Paisley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Lena","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byomkesh","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deok Ryun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Attridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Carbis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Holmgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipika","family":"Sur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.09.008_bib1","unstructured":"WHO. Cholera in Zimbabwe. Update 4. 2009 [cited 2009 July 28, 2009]; Available from: http:\/\/www.who.int\/csr\/don\/2009_06_09\/en\/index.html."},{"key":"10.1016\/j.vaccine.2009.09.008_bib2","unstructured":"OCHA. Cholera situation in Zimbabwe: daily cholera update 24 July 2009. [cited 13 August 2009]; Available from: http:\/\/ochaonline.un.org\/CholeraSituation\/CholeraSituation\/tabid\/5399\/language\/en-US\/Default.aspx."},{"issue":"16","key":"10.1016\/j.vaccine.2009.09.008_bib3","first-page":"117","article-title":"Cholera vaccines","volume":"76","year":"2001","journal-title":"Wkly Epidemiol Rec"},{"issue":"7","key":"10.1016\/j.vaccine.2009.09.008_bib4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jama.279.7.521","article-title":"Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis","volume":"279","author":"Naficy","year":"1998","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.vaccine.2009.09.008_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jama.280.7.600-a","article-title":"Cholera vaccine in refugee settings","volume":"280","author":"Sack","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.09.008_bib6","series-title":"Use of the two-dose oral cholera vaccine in the context of a major natural disaster report of a mass vaccination campaign in Aceh Province, Indonesia","year":"2005"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.008_bib7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.008_bib8","doi-asserted-by":"crossref","first-page":"e2323","DOI":"10.1371\/journal.pone.0002323","article-title":"A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India","volume":"3","author":"Mahalanabis","year":"2008","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.008_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/368132","article-title":"Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine","volume":"187","author":"Albert","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.008_bib10","series-title":"Guideline for industry\u2014clinical safety data management: definitions and standards for expedited reporting","article-title":"Expert Working Group (Efficacy) of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","year":"1995"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.008_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/JCM.24.2.203-209.1986","article-title":"Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease","volume":"24","author":"Jertborn","year":"1986","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.008_bib12","first-page":"383","article-title":"Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139","volume":"9","author":"Attridge","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.09.008_bib13","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1128\/IAI.73.10.6577-6583.2005","article-title":"Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh","volume":"73","author":"Qadri","year":"2005","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.008_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/IAI.64.1.10-15.1996","article-title":"Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera","volume":"64","author":"Losonsky","year":"1996","journal-title":"Infect Immun"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2009.09.008_bib15","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1016\/S0264-410X(02)00317-1","article-title":"Sample size determination for phase II studies of new vaccines","volume":"20","author":"Rao","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.008_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/infdis\/155.1.79","article-title":"B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity","volume":"155","author":"Clemens","year":"1987","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2009.09.008_bib17","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/IAI.71.7.3909-3913.2003","article-title":"Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation","volume":"71","author":"Karlsen","year":"2003","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.008_bib18","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/IAI.61.9.3994-3997.1993","article-title":"Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels","volume":"61","author":"Gotuzzo","year":"1993","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.008_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.4269\/ajtmh.1999.61.869","article-title":"Safety, immunogenicity, and lot stability of the whole cell\/recombinant B subunit (WC\/rCTB) cholera vaccine in Peruvian adults and children","volume":"61","author":"Taylor","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.09.008_bib20","unstructured":"Guidelines for the production and control of inactivated oral cholera vaccines. WHO Expert Committee on Biological Standardization. Fifty-second report. Geneva, Switzerland: WHO; 2001."},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.008_bib21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CDLI.4.3.264-269.1997","article-title":"Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity","volume":"4","author":"Losonsky","year":"1997","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T06:48:33Z","timestamp":1590130113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09013322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":21,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09013322"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}